Previously, it was reported that miR17-5p could repress RBL2, also named P130, to release activating transcription factor E2F4 or CTNNB1, which promoted tumor progression by inducing activation of multiple targeted genes like CCND1 and CCNE1 etc., [10, 11]. This evidence concerns the gene RBL2 and neoplasm.